viewOpyl Ltd

Opyl granted trading halt ahead of equity raising announcement

Opyl develops digital tools that improve the healthcare experience for patients, deliver deep market insights from social media data and improve the efficiency and value of the clinical research process.

Opyl Ltd - Opyl in trading halt ahead of equity raising news by way of share placement
The company reports growing interest in its digital and social media offerings

Opyl Ltd (ASX:OPL) has an equity raising announcement upcoming and has been granted a trading halt by the ASX.

In its application for the halt, the company said the proposed equity raising would be conducted by way of a share placement.

The trading halt will be in place until the beginning of regular trade on Monday, June 22, or when an announcement is released to the market, whichever occurs earliest.

Shares last traded at 13 cents and since the close on March 23 have risen from 4 cents to a high of 15.5 cents at the close on June 4.

New contracts

In May, the company signed two new contracts that are expected to increase revenue over the following three quarters.

Opyl also has several active additional proposals in the market as a result of an intensive business development campaign collaborating with huumun.

Chief executive officer Michelle Gallaher said the company remained on track for a cash flow neutral quarter or better, as additional contracts moved it towards cash flow positive operations

She said: “The rapid transition to focus on digital channels and data optimisation in healthcare as a result of COVID-19 is starting to positively impact the business as more and more companies realise the value that Opyl can bring to their programs, technologies and healthcare interests.

“Each day we get more companies coming to us to help them with their clinical trial recruitment or market insights.”

Quick facts: Opyl Ltd

Price: 0.099 AUD

Market: ASX
Market Cap: $3.65 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Opyl Ltd named herein, including the promotion by the Company of Opyl Ltd in any Content on the Site, the Company receives from said issuer...



Full interview: Opyl is new name of digital health track company ShareRoot

Opyl Limited (ASX:OPL) chief executive officer Michelle Gallaher updates Proactive on the renaming of the global digital health track company formerly known as ShareRoot Ltd (ASX:SRO). This heralds the company’s entry into the rapidly expanding global digital health and artificial...

on 9/12/19

2 min read